Français
ItalianoBond Celgene Corp 2.875% ( US151020AQ72 ) in USD
| Issuer | Celgene Corp | ||||||
| Market price | 100.00 % ⇌ | ||||||
| Country |  United States
|
||||||
| ISIN code |
 US151020AQ72 ( in USD )
|
||||||
| Interest rate | 2.875% per year ( payment 2 times a year) | ||||||
| Maturity | 14/08/2020 - Bond has expired | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | 2 000 USD | ||||||
| Total amount | 1 500 000 000 USD | ||||||
| Cusip | 151020AQ7 | ||||||
| Standard & Poor's ( S&P ) rating | N/A | ||||||
| Moody's rating | N/A | ||||||
| Detailed description |
Celgene Corporation was a biopharmaceutical company acquired by Bristol Myers Squibb in 2019, known for its development and commercialization of cancer therapies and other immunology treatments. The Bond issued by Celgene Corp ( United States ) , in USD, with the ISIN code US151020AQ72, pays a coupon of 2.875% per year. The coupons are paid 2 times per year and the Bond maturity is 14/08/2020 |
||||||
| |||||||